Experimental stem cell therapy: Biohierarchies and bionetworking in japan and india

Social Studies of Science

Volumn 41, Issue 5, 2011, Pages 645-666

  Sleeboom Faulkner, Margaret ^a   Patra, Prasanna Kumar ^b  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b UTKAL UNIVERSITY   (India)

Author keywords

biohierarchy; bionetworking; India; Japan; stem cell therapy

Indexed keywords

ADULT; ARTICLE; COMMERCIAL PHENOMENA; ECONOMICS; ETHICS; HUMAN; HUMAN EXPERIMENT; INDIA; INTERNATIONAL COOPERATION; JAPAN; MEDICAL RESEARCH; ORGANIZATION AND MANAGEMENT; PATIENT SELECTION; PUBLIC-PRIVATE PARTNERSHIP; STEM CELL TRANSPLANTATION;

ADULT; BIOMEDICAL RESEARCH; COMMERCE; HUMAN EXPERIMENTATION; HUMANS; INDIA; INTERNATIONALITY; JAPAN; PATIENT SELECTION; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; STEM CELL TRANSPLANTATION;

EID: 80052799601     PISSN: 03063127     EISSN: 14603659     Source Type: Journal    
DOI: 10.1177/0306312711409792     Document Type: Article

References (40)

1. Bharadwaj A,Glasner PLocal Cells, Global Science: The Rise of Embryonic Stem Cell Research in India. London and New York: Routledge; 2009:.
2. Cooper M.Experimental labour: Offshoring clinical trials to China.East Asian Science, Technology and Society. 2008;2 (1): 73-92.
3. Guidelines for Stem Cell Research and Therapy. New Delhi: Director General, DBT-ICMR; 2007:.
4. Express Pharma (2006) Stem cell research: The Indian perspective. Available at http://www.expresspharmaonline.com/20061115/anniversaryspecial10.shtml (accessed 6 May 2011).
5. Fukuda E,Nakai MNihon no Yaku ha dokoka okashii!. Tokyo: Seishisha; 2008:.
6. Geissler PW,Kelly A,imoukhuede B,Pool R.'He is now like a brother, I can even give him some blood': Relational ethics and material exchanges in a malaria vaccine 'trial community' in The Gambia.Social Science & Medicine. 2008;67 (5): 696-707.
7. Gieryn TF.Boundary-work and the demarcation of science from non-science: Strains and interests in professional ideologies of scientists.American Sociological Review. 1983;48 (6): 781-795.
8. Stem cell trials to start at AIIMS.Hindustan Times. 2006;:.
9. Indian Council of Medical Research (2007) Guidelines for stem cell research and therapy. Available at http://icmr.nic.in/stem_cell/stem_cell_guidelines.pdf (accessed 13 March 2011).
10. International Society for Stem Cell Research (2008) Frequently asked questions. ISSCR. Available at www.isscr.org/science/faq.htm (accessed 13 March 2011).
11. Japan Ministry of Health, Labour and Welfare (2006) Guidelines for clinical research using human stem cells [in Japanese]. Available at www.mhlw.go.jp/bunya/kenkou/iryousaisei01/pdf/01.pdf (accessed 13 March 2011).
12. KhanA (2007) Are we stemming growth? Express Pharma Online. Available at www.expresspharmaonline.com/20070615/management02.shtml (accessed 20 January 2009).
13. KiatpongsanSSippD (2008) Offshore stem cell treatments. Nature Reports Stem Cells, 3December. Available at www.nature.com/stemcells/2008/0812/081203/full/stemcells.2008.151.html (accessed 13 January 2009).
14. Kleinman AWriting at the Margin: Discourse between Anthropology and Medicine. Berkeley: University of California Press; 1995:.
15. Kuo WH.Understanding race at the frontier of pharmaceutical regulation: An analysis of the racial difference debate at the ICH.Journal of Law, Medicine and Ethics. 2008;36 (3): 498-505.
16. Larkin JStrategic Reputation Risk Management. New York: Palgrave MacMillan; 2003:.
17. Nowotny H,Scott P,Gibbons MRe-Thinking Science: Knowledge and the Public in an Age of Uncertainty. Oxford: Polity Press; 2001:.
18. Partridge WM.Translational science: What it is and why it is so important.Drug Discovery Today. 2003;8 (18): 813-815.
19. Passier R,van Laake LW,Mummery CL.Review article: Stem cell based therapy and lessons from the heart.Nature. 2008;453 (May): 322-329.
20. Patra PK,Sleeboom-Faulkner M.Bionetworking: Experimental stem cell therapy and patient recruitment in India.Anthropology & Medicine. 2009;16 (2): 147-163.
21. Patra PK,Sleeboom-Faulkner M.Recruiter-patients as ambiguous symbols: Bionetworking and stem cell therapy in India.New Genetics and Society. 2011;30(2):.
22. Petryna AGlobal Pharmaceuticals: Ethics, Markets, Practices. Petryna ALakoff AKleinman A, ed. Durham, NC, and London: Duke University Press; 2007:33-60.
23. Rothwell PM.Treating individuals 1. External validity of randomised controlled trials: 'To whom do the results of this trial apply?'.Lancet. 2005;365 (9453): 82-93.
24. Saegusa A.Looser ties urged for Japanese scientists.Nature. 1999;398 (643(6729)): 643.
25. Sahlins MD.Poor man, rich man, big man, chief: Political types in Melanesia and Polynesia.Comparative Studies in Society and History. 1963;5 (3): 285-303.
26. Salter B.Governing stem cell science in China and India: Emerging economies and the global politics of innovation.New Genetics and Society. 2008;27 (2): 145-159.
27. Sharma A.Stem cell research in India: Emerging scenario and policy concerns.Asian Biotechnology and Development Review. 2006;8 (3): 43-53.
28. Sleeboom-Faulkner M.Claiming the futures of human embryonic stem cell research in Japan: Minority voices and their amplifiers.Science as Culture. 2008;17 (1): 85-97.
29. Sleeboom-Faulkner M.National risk signatures and human embryonic stem cell research in Mainland China.Health, Risk and Society. 2010;12 (5): 491-511.
30. Sleeboom-Faulkner M,Patra PK.The bioethical vacuum: National policies on human embryonic stem cell research in India and China.Journal of International Biotechnology Law. 2008;5 (6): 221-234.
31. Slingby BT,Noriko N,Akira A.Administrative legislation in Japan: Guidelines on scientific and ethical standards.Cambridge Quarterly of Healthcare Ethics. 2004;13:245-253.
32. Star SL,Griesemer JR.Institutional ecology, 'translations' and boundary objects: Amateurs and professionals in Berkeley's Museum of Vertebrate Zoology, 1907-39.Social Studies of Science. 1989;19 (3): 387-420.
33. Strauer BE,Kornowski R.Stem cell therapy in perspective.Journal of the American Heart Association. 2003;107:929-934.
34. Sundar Rajan KBiocapital: The Constitution of Postgenomic Life. Durham/London: Duke University Press; 2006:.
35. Sundar Rajan K.Experimental values: Indian clinical trials and surplus health.New Left Review. 2007;45:67-88.
36. Wahlberg A,Streitfellner TTechnologies de l'espoir. Les débats publics autour de l'innovation médicale. Leibing ATournay V, ed. Montreal: Presses Universitaires de Laval; 2011:.
37. Wainwright SP,Williams C,Michael M,Farsides B,Cribb A.From bench to bedside? Biomedical scientists' expectations of stem cell science as a future therapy for diabetes.Social Science and Medicine. 2006;63 (8): 2052-2064.
38. Waldby C,Mitchell RTissue Economies: Blood, Organs and Cell Lines in Late Capitalism. Durham, NC and London: Duke University Press; 2007:.
39. Will CM.The alchemy of clinical trials.BioSocieties. 2007;2 (1): 85-99.
40. Yuasa JShinyaku Kudasai! Duraggu Ragu to Inochi no Hazami de. Tokyo: Shinchosha; 2007:.